Europe Small Molecule Cancer Drug Industry 2016 Deep Market Research Report
- QYR543328
- 134 Pages
- April 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Small Molecule Cancer Drug market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Small Molecule Cancer Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 153 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Small Molecule Cancer Drug
1.1.1 Definition of Small Molecule Cancer Drug
1.1.2 Specifications of Small Molecule Cancer Drug
1.2 Classification of Small Molecule Cancer Drug
1.3 Applications of Small Molecule Cancer Drug
1.4 Industry Chain Structure of Small Molecule Cancer Drug
1.5 Industry Overview of Small Molecule Cancer Drug
1.6 Industry Policy Analysis of Small Molecule Cancer Drug
1.7 Industry News Analysis of Small Molecule Cancer Drug
2 Manufacturing Cost Structure Analysis of Small Molecule Cancer Drug
2.1 Bill of Materials (BOM) of Small Molecule Cancer Drug
2.2 BOM Price Analysis of Small Molecule Cancer Drug
2.3 Labor Cost Analysis of Small Molecule Cancer Drug
2.4 Depreciation Cost Analysis of Small Molecule Cancer Drug
2.5 Manufacturing Cost Structure Analysis of Small Molecule Cancer Drug
2.6 Manufacturing Process Analysis of Small Molecule Cancer Drug
2.7 Europe Price, Cost and Gross of Small Molecule Cancer Drug 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Europe Key Small Molecule Cancer Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of Europe Small Molecule Cancer Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Europe Small Molecule Cancer Drug Key Manufacturers in 2015
4 Production Analysis of Small Molecule Cancer Drug by Regions, Type, and Applications
4.1 Europe Production of Small Molecule Cancer Drug by Regions 2011-2016
4.2 Europe Production of Small Molecule Cancer Drug by Type 2011-2016
4.3 Europe Sales of Small Molecule Cancer Drug by Applications 2011-2016
4.4 Price Analysis of Europe Small Molecule Cancer Drug Key Manufacturers in 2015
4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Small Molecule Cancer Drug 2011-2016
5 Consumption Volume and Consumption Value Analysis of Small Molecule Cancer Drug by Regions
5.1 Europe Consumption Volume of Small Molecule Cancer Drug by Regions 2011-2016
5.2 Europe Consumption Value of Small Molecule Cancer Drug by Regions 2011-2016
5.3 Europe Consumption Price Analysis of Small Molecule Cancer Drug by Regions 2011-2016
6 Analysis of Small Molecule Cancer Drug Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Small Molecule Cancer Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Small Molecule Cancer Drug 2014-2015
6.3 Sales Overview of Small Molecule Cancer Drug 2011-2016
6.4 Supply, Consumption and Gap of Small Molecule Cancer Drug 2011-2016
6.5 Import, Export and Consumption of Small Molecule Cancer Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Small Molecule Cancer Drug 2011-2016
7 Analysis of Small Molecule Cancer Drug Industry Key Manufacturers
7.1 Bayer
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Cadila Pharmaceutical
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Astrazeneca
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Johnson & Johnson
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Eli Lily
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Boehringer Ingelheim
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Roche
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Merck
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Novartis
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Small Molecule Cancer Drug Product Types
8.5 Market Share Analysis of Different Small Molecule Cancer Drug Price Levels
8.6 Gross Margin Analysis of Different Small Molecule Cancer Drug Applications
9 Marketing Trader or Distributor Analysis of Small Molecule Cancer Drug
9.1 Marketing Channels Status of Small Molecule Cancer Drug
9.2 Traders or Distributors of Small Molecule Cancer Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Small Molecule Cancer Drug
9.4 Europe Import, Export and Trade Analysis of Small Molecule Cancer Drug
10 Development Trend of Small Molecule Cancer Drug Industry 2016-2021
10.1 Capacity and Production Overview of Small Molecule Cancer Drug 2016-2021
10.2 Production Market Share by Product Types of Small Molecule Cancer Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Small Molecule Cancer Drug 2016-2021
10.4 Europe Sales of Small Molecule Cancer Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Small Molecule Cancer Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Small Molecule Cancer Drug 2016-2021
11 Industry Chain Suppliers of Small Molecule Cancer Drug with Contact Information
11.1 Major Raw Materials Suppliers of Small Molecule Cancer Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Small Molecule Cancer Drug with Contact Information
11.3 Major Players of Small Molecule Cancer Drug with Contact Information
11.4 Key Consumers of Small Molecule Cancer Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Small Molecule Cancer Drug
12 New Project Investment Feasibility Analysis of Small Molecule Cancer Drug
12.1 New Project SWOT Analysis of Small Molecule Cancer Drug
12.2 New Project Investment Feasibility Analysis of Small Molecule Cancer Drug
13 Conclusion of the Europe Small Molecule Cancer Drug Industry 2016 Market Research Report
Figure Picture of Small Molecule Cancer Drug
Table Product Specifications of Small Molecule Cancer Drug
Table Classification of Small Molecule Cancer Drug
Figure Europe Sales Market Share of Small Molecule Cancer Drug by Product Types in 2015
Table Applications of Small Molecule Cancer Drug
Figure Europe Sales Market Share of Small Molecule Cancer Drug by Applications in 2015
Figure Industry Chain Structure of Small Molecule Cancer Drug
Table Europe Industry Overview of Small Molecule Cancer Drug
Table Industry Policy of Small Molecule Cancer Drug
Table Industry News List of Small Molecule Cancer Drug
Table Bill of Materials (BOM) of Small Molecule Cancer Drug
Table Bill of Materials (BOM) Price of Small Molecule Cancer Drug
Table Labor Cost of Small Molecule Cancer Drug
Table Depreciation Cost of Small Molecule Cancer Drug
Table Manufacturing Cost Structure Analysis of Small Molecule Cancer Drug in 2015
Figure Manufacturing Process Analysis of Small Molecule Cancer Drug
Table Europe Price Analysis of Small Molecule Cancer Drug 2011-2016 (USD/Dose)
Table Europe Cost Analysis of Small Molecule Cancer Drug 2011-2016 (USD/Dose)
Table Europe Gross Analysis of Small Molecule Cancer Drug 2011-2016
Table Capacity (K Dose) and Commercial Production Date of Europe Small Molecule Cancer Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of Europe Key Small Molecule Cancer Drug Manufacturers in 2015
Table R&D Status and Technology Source of Europe Small Molecule Cancer Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of Europe and Europe Small Molecule Cancer Drug Key Manufacturers in 2015
Table Europe Production of Small Molecule Cancer Drug by Regions 2011-2016 (K Dose)
Table Europe Production Market Share of Small Molecule Cancer Drug by Regions 2011-2016
Figure Europe Production Market Share of Small Molecule Cancer Drug by Regions in 2014
Figure Europe Production Market Share of Small Molecule Cancer Drug by Regions in 2015
Table Europe Production of Small Molecule Cancer Drug by Types in 2011-2016 (K Dose)
Table Europe Production Market Share of Small Molecule Cancer Drug by Type in 2011-2016
Figure Europe Production Market Share of Small Molecule Cancer Drug by Type in 2014
Figure Europe Production Market Share of Small Molecule Cancer Drug by Type in 2015
Table Europe Sales of Small Molecule Cancer Drug by Applications 2011-2016 (K Dose)
Table Europe Production Market Share of Small Molecule Cancer Drug by Applications 2011-2016
Figure Europe Production Market Share of Small Molecule Cancer Drug by Applications in 2014
Figure Europe Production Market Share of Small Molecule Cancer Drug by Applications in 2015
Table Price Comparison of Europe Small Molecule Cancer Drug Key Manufacturers in 2015 (USD/Dose)
Table Europe Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Small Molecule Cancer Drug 2011-2016
Table Europe Consumption Volume of Small Molecule Cancer Drug by Regions 2011-2016 (K Dose)
Table Europe Consumption Volume Market Share of Small Molecule Cancer Drug by Regions 2011-2016
Figure Europe Consumption Volume Market Share of Small Molecule Cancer Drug by Regions in 2014
Figure Europe Consumption Volume Market Share of Small Molecule Cancer Drug by Regions in 2015
Table Europe Consumption Value of Small Molecule Cancer Drug by Regions 2011-2016 (M USD)
Table Europe Consumption Value Market Share of Small Molecule Cancer Drug by Regions 2011-2016
Figure Europe Consumption Value Market Share of Small Molecule Cancer Drug by Regions in 2014
Figure Europe Consumption Value Market Share of Small Molecule Cancer Drug by Regions in 2015
Table Consumption Price of Small Molecule Cancer Drug by Regions 2011-2016 (USD/Dose)
Table Europe and Major Manufacturers Capacity of Small Molecule Cancer Drug 2011-2016 (K Dose)
Table Europe Capacity Market Share of Major Small Molecule Cancer Drug Manufacturers 2011-2016
Table Europe and Major Manufacturers Production of Small Molecule Cancer Drug 2011-2016 (K Dose)
Table Europe Production Market Share of Major Small Molecule Cancer Drug Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales of Small Molecule Cancer Drug 2011-2016 (K Dose)
Table Europe Sales Market Share of Major Small Molecule Cancer Drug Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales Revenue of Small Molecule Cancer Drug 2011-2016 (M USD)
Table Europe Sales Revenue Market Share of Major Small Molecule Cancer Drug Manufacturers 2011-2016
Figure Europe Capacity (K Dose), Production (K Dose) and Growth Rate of Small Molecule Cancer Drug 2011-2016
Figure Europe Capacity Utilization Rate of Small Molecule Cancer Drug 2011-2016
Figure Europe Sales Revenue (M USD) and Growth Rate of Small Molecule Cancer Drug 2011-2016
Figure Europe Production Market Share of Major Small Molecule Cancer Drug Manufacturers in 2014
Figure Europe Production Market Share of Major Small Molecule Cancer Drug Manufacturers in 2015
Figure Europe Sales Market Share of Major Small Molecule Cancer Drug Manufacturers in 2014
Figure Europe Sales Market Share of Major Small Molecule Cancer Drug Manufacturers in 2015
Figure Europe Sales (K Dose) and Growth Rate of Small Molecule Cancer Drug 2011-2016
Table Europe Supply, Consumption and Gap of Small Molecule Cancer Drug 2011-2016 (K Dose)
Table Europe Import, Export and Consumption of Small Molecule Cancer Drug 2011-2016 (K Dose)
Table Price of Europe Small Molecule Cancer Drug Major Manufacturers 2011-2016 (USD/Dose)
Table Gross Margin of Europe Small Molecule Cancer Drug Major Manufacturers 2011-2016
Table Europe and Major Manufacturers Revenue of Small Molecule Cancer Drug 2011-2016 (M USD)
Table Europe Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Small Molecule Cancer Drug 2011-2016
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Bayer
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Bayer 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Bayer 2011-2016
Table Bayer Small Molecule Cancer Drug SWOT Analysis
Table Cadila Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Cadila Pharmaceutical
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Cadila Pharmaceutical 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Cadila Pharmaceutical 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Cadila Pharmaceutical 2011-2016
Table Cadila Pharmaceutical Small Molecule Cancer Drug SWOT Analysis
Table Astrazeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Astrazeneca
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Astrazeneca 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Astrazeneca 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Astrazeneca 2011-2016
Table Astrazeneca Small Molecule Cancer Drug SWOT Analysis
Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Johnson & Johnson
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Johnson & Johnson 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Johnson & Johnson 2011-2016
Table Johnson & Johnson Small Molecule Cancer Drug SWOT Analysis
Table Eli Lily Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Eli Lily
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lily 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Eli Lily 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Eli Lily 2011-2016
Table Eli Lily Small Molecule Cancer Drug SWOT Analysis
Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Boehringer Ingelheim
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Boehringer Ingelheim 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Boehringer Ingelheim 2011-2016
Table Boehringer Ingelheim Small Molecule Cancer Drug SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Roche
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Roche 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Roche 2011-2016
Table Roche Small Molecule Cancer Drug SWOT Analysis
Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Merck
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Merck 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Merck 2011-2016
Table Merck Small Molecule Cancer Drug SWOT Analysis
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Small Molecule Cancer Drug Picture and Specifications of Novartis
Table Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novartis 2011-2016
Figure Small Molecule Cancer Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Novartis 2011-2016
Figure Small Molecule Cancer Drug Production (K Dose) and Europe Market Share of Novartis 2011-2016
Table Novartis Small Molecule Cancer Drug SWOT Analysis
Table Small Molecule Cancer Drug Price by Regions 2011-2016
Table Small Molecule Cancer Drug Price by Product Types 2011-2016
Table Small Molecule Cancer Drug Price by Companies 2011-2016
Table Small Molecule Cancer Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Small Molecule Cancer Drug by Regions 2011-2016 (USD/Dose)
Table Price of Different Small Molecule Cancer Drug Product Types (USD/Dose)
Table Market Share of Different Small Molecule Cancer Drug Price Level
Table Gross Margin of Different Small Molecule Cancer Drug Applications
Table Marketing Channels Status of Small Molecule Cancer Drug
Table Traders or Distributors of Small Molecule Cancer Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Small Molecule Cancer Drug (USD/Dose) in 2015
Table Europe Import, Export, and Trade of Small Molecule Cancer Drug (K Dose)
Figure Europe Capacity (K Dose), Production (K Dose) and Growth Rate of Small Molecule Cancer Drug 2016-2021
Figure Europe Capacity Utilization Rate of Small Molecule Cancer Drug 2016-2021
Table Europe Small Molecule Cancer Drug Production by Type 2016-2021 (K Dose)
Table Europe Small Molecule Cancer Drug Production Market Share by Type 2016-2021
Figure Europe Production Market Share of Small Molecule Cancer Drug by Type in 2021
Figure Europe Sales (K Dose) and Growth Rate of Small Molecule Cancer Drug 2016-2021
Figure Europe Sales Revenue (Million USD) and Growth Rate of Small Molecule Cancer Drug 2016-2021
Figure Europe Sales of Small Molecule Cancer Drug by Applications 2016-2021 (K Dose)
Table Europe Production Market Share of Small Molecule Cancer Drug by Applications 2016-2021
Figure Europe Production Market Share of Small Molecule Cancer Drug by Applications in 2021
Table Europe Production, Import, Export and Consumption of Small Molecule Cancer Drug 2016-2021 (K Dose)
Table Europe Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Small Molecule Cancer Drug 2016-2021
Table Major Raw Materials Suppliers of Small Molecule Cancer Drug with Contact Information
Table Manufacturing Equipment Suppliers of Small Molecule Cancer Drug with Contact Information
Table Major Players of Small Molecule Cancer Drug with Contact Information
Table Key Consumers of Small Molecule Cancer Drug with Contact Information
Table Supply Chain Relationship Analysis of Small Molecule Cancer Drug
Table New Project SWOT Analysis of Small Molecule Cancer Drug
Table New Project Investment Feasibility Analysis of Small Molecule Cancer Drug
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
